GoodRx & Criteo Revised $32 Million Data Privacy Settlement Gets First Approval
A federal court has granted preliminary approval to a revised $32 million settlement in a class action lawsuit over data privacy claims against GoodRx and advertising technology company Criteo. The case centers on alleged improper sharing of users' personal health and medication data.
Why this matters: GoodRx is a health app. People use it to find cheaper prescriptions, which means it knows what drugs they take and why. That is sensitive medical information. The allegation here is that this data was handed off to an ad tech company. People did not sign up for their health details to fuel advertising. Thirty-two million dollars sounds like accountability, but in class action settlements most affected users see a small check while the companies move on. The more important question is whether the data-sharing actually stopped.
Who should care: Cybersecurity · Privacy officers · Administrators · Lawyers · Compliance · Healthcare professionals · General readers · Policy
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.